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Effect of mersalyl on the thick ascending limb of Henle's loop.
The cortical portion of the thick ascending limb of Henle's loop
was dissected from rabbit kidneys and perfused in vitro. There
was active chloride transport resulting in net sodium chloride
reabsorption from the tubule lumen, with the electrical potential
difference (PD) oriented positive in the lumen. The addition of
mersalyl ( iO M) to the lumen caused the PD and net Cl flux
to decrease, indicating inhibition of the active Cl transport. The
decrease in PD caused by the drug in the lumen was approxi-
mately 50% at concentrations equal to or greater than iO M,
and the decrease in CI transport (measured at 3 x l0 M) was
similar in magnitude. Addition of p-chloromercuribenzoate to
the tubule lumen immediately reversed the effect of mersalyl
administration. The diuresis caused by mercurials in vivo simi-
larly is reversed by p-chloromercuribenzoate administration.
Therefore, the effect of mersalyl on the isolated perfused thick
ascending limbs of Henle's loop in vitro can be identified with
its diuretic effect in vivo. Mersalyl in the bath was inactive ex-
cept at a higher concentration (10 M), and the effect was not
reversible. We conclude that the diuretic effect of mercurials is
due, at least in part, to inhibition by these drugs in the tubule
lumen of active Cl transport in the thick ascending limb of
Henle's loop.
Effet du mersalyl sur Ia partie large de Ia branche ascendante
de I'anse de Henle. La portion corticale de Ia partie large de Ia
branche ascendante de l'anse de Henle a été disséquée dans des
reins de lapin et perfusée in vitro. II existe un transport actif de
chlore ayant pour consequence une soustraction nette de NaCI
a Ia lumière tubulaire et une difference de potentiel telle que Ia
lumiCre est positive. Le mersalyl ( lO M) dans Ia lumière induit
une diminution de Ia difference de potentiel et du flux net de
chlore, ce qui traduit l'inhibition du transport actif du chlore.
La diminution de Ia difference de potentiel est approximative-
ment de 50% a des concentrations égales ou supérieures a
iO M et Ia diminution du transport de chiore, mesurée a
3 x iO M,est du mCme ordre de grandeur. L'addition dep-chloro-
mercuribenzoate a Ia lumiCre tubulaire annule immédiatement
l'effet du mersalyl. La diurCse induite in vivo par les mercuriels
est, de Ia mCme facon, annulée par Ic p-chloromercuribenzoate.
Ainsi, l'effet du mersalyl sur la partie large ascendante de l'anse
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de Henle isolée et perfusee peut être identifié a son effet diuretique
in vivo. Le mersalyl dans Ic bain est inefficace, excepté a une
concentration plus élevée (10—i M) et alors I'effet n'est pas
reversible. Nous concluons que l'effet diurétique des mercuriels
est lie, au moms en partie, a l'action inhibitrice de ces drogues
sur le transport actif de chlore dans Ia partie large de Ia branche
ascendante de l'anse de Henle.
Mercurial diuretics were extensively used and studied
until they were supplanted in the past few years by more
effective agents. There are many excellent reviews of the
pharmacology of the mercurials [1—4]. Despite numerous
investigations, however, it had never been possible to
study directly the specific renal action of the drug that is
responsible for the diuresis. Even the site of action within
the nephron had been uncertain, and most tubule segments
have been implicated at one time or another [3]. The most
recent studies, accomplished by micropuncture in the dog,
implicate the loop of Henle [5, 6] and it seems likely that,
despite the conflicting evidence, the thick ascending limb
of Henle's loop is the major site of action of mercurials [2].
This nephron segment is not accessible to micropuncture,
but has recently been studied directly by means of in vitro
perfusion of tubule fragments dissected from rabbit
kidneys [7, 8]. Its permeability to water is low, There is net
sodium chloride reabsorption which results in lowering of
the NaCI concentration in the lumen. The potential dif-
ference (PD), which is positive in the lumen, is caused by
the active transport of chloride out of the tubule lumen.
The reabsorption of Na is largely passive along the electrical
gradient. Net NaCI transport and the electrical PD are
both inhibited by the addition of ouabain to the bath [7]
and furosemide to the lumen [9].
In the present studies the direct effect of the mercurial
diuretic mersalyl on the isolated perfused cortical thick
ascending limb of Henle's loop has been studied. Mersalyl
was chosen since it causes a diuresis in rabbits [10] and
contains no theophylline, which might complicate the
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interpretation [11]. The major finding is that mersalyl in
the lumen inhibits the net Cl transport and the electrical
PD, thus indicating that the drug inhibits active Cl transport
in this segment.
Methods
The method employed in these studies has previously
been described in detail [7, 9, 12] and is summarized below
with additions and modifications.
Cortical segments from thick ascending limbs of Henle's
loop were dissected from rabbit kidney and were perfused
at 37° C using concentric glass pipets. The pipet system
used includes [13] 1) a means of changing perfusion fluid
with the tubule in place, 2) a means of positioning liquid
dielectric (Sylgard 184) at the outside of the tubule at both
ends for insulation and 3) a volumetric constriction pipet
for collection of tubule fluid. The bath solutions were
bubbled with 95% 02 + 5% CO2 gas mixture before and
during the experiment.
The tubules were dissected at room temperature in the
saline buffer solution that was used in the bath during
perfusion. It contained NaCI, 115 mM; KCI, 5 mM; Na
HCO3, 25 mM; Na acetate, 10mM; CaCl2, 1 mr.t; MgSO4,
1.2 mM; NaH2PO4, 1.2 mM; and glucose, 5 m plus 5% v/v
rabbit serum. The perfusate contained NaCI, 150 mM;
K2HPO4, 2.5 mM; CaC12, 1.0 mM; and MgSO4, 1.2 mM,
adjusted to pH 7.4 (unless otherwise noted) with HCI.
Perfusions were carried out by gravity. Perfusion rate was
measured only in the experiments in which Cl transport
was determined (Table 1). In the other experiments (in
which only PD was measured), the perfusion pressure was
initially adjusted upwards to achieve a flow rate greater than
the slow rates at which the PD is flow-dependent [7]. The
Na and K concentrations were checked in all of the per-
fusion fluids and baths, using flame photometry (IL), and
osmolality, with the use of a freezing point apparatus
(Bowman-Aminco) [14]. Chloride concentration was
measured in bulk solutions using a chioridometer (Cotlove-
Aminco) [15] and in microsamples of perfused and collected
fluid using a modification [12] of the Ramsay method (16].
The transepithelial electrical PD was measured between
calomel cells connected to the fluids in the bath and perfu-
sion pipet with bridges containing 0.16 M NaCl agar. The
PD was displayed on an oscilloscope (Tektronix 561A) or
a recorder (Hewlett Packard 680 M) connected by an
amplifier (Bak ELSA—3 or 4). The PD was not corrected
for liquid junction potentials since they are small and
cannot be readily calculated for the complex solutions used
[17] (the liquid junction potential with the solutions just
listed is less than + 1.5 my, which would be subtracted
from the recorded PD for correction).
Solutions of mersalyl acid (Sterling Winthrop Research
Institute) lost effectiveness on standing and, therefore,
were freshly prepared during each experiment. P-chloro-
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Mean 8.13 4.64 6.89
SEM 0.77 0.62 0.86
a Each result is the mean of three or more collection periods
over 15 to 30 mm. During the postcontrol periods, p-chloro-
mercuribenzoate (PCMB) was either added to the mersalyl
already present in the lumen (3 x l05M, tubules 2, 3, and 6)
or else PCMB replaced the mersalyl (3 x iO M of PCMB,
tubules 1 and 4; l0— M, tubules 5, 7 and 8). The drug(s) were
continuously present during the postcontrol periods except in
tubules 7 and 8 from which the PCMB was removed after being
present for only 2 to 3 mm. The mean paired differences were as
follows: control minus mersalyl, 3.51 0.5 5EM (P<0.01); post-
control minus mersalyl, 2.25 0.58 (P< 0.01); and control
minus after control, 1.25 0.17 (P< 0.01). Mean Cl concentra-
tions were as follows: 120 mEq/liter1 in the bath, 152 mEq/
liters—1 in the perf used fluid, and 108 mEq/liters in the control-
collected tubule fluid. Mean tubule length was 1.26 mm; mean
perfusion rate, 1.34 n1/min. Net chloride transport was cal-
culated, as previously [8], from the concentrations of Cl in the
perfused and collected fluid and the perfusion rate (assuming
no net fluid transport).
tralized with NaOH prior to addition. Cysteine (Calbio-
chem) solutions were bubbled with N2 gas prior to combina-
tion with HgCl2 (Merck, reagent grade). The pH of each
solution was measured and was adjusted with HCI to the
control pH (or other, as noted). No rabbit serum was
added to any solutions containing the drugs in order to
avoid possible protein binding.
Results are given as mean (number of tubules
studied). Statistical significance was estimated using
Student's t test.
Results
The mean electrical PD across the epithelium of the
cortical thick ascending limb of Henle's loop is 6.4 2.0 SD
my (lumen positive) when the solutions in the lumen and
bath contain equal concentrations of Na [7]. The PD
results from the active transport of Cl across the epithelium
[7], and drives the Na transport, which is largely passive.
Addition of mersalyl to the lumen caused the PD to
decrease by approximately one-half (Fig. 1 through 4).
Net Cl reabsorption was similarly inhibited (Table 1).
Therefore, the addition of mersalyl to the lumen inhibits
Table 1. Effect of mersalyl (3 x l0 M) in the lumen on the thick
ascending limb of Henle's loop
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Minutes
Fig. 1. Addition of mersalyl to the lumen of the thick ascending
limb of Henle's loop caused the transepithelial potential differ-
ence (PD) to decrease reversibly.
tuti
90 -
Fig. 3. Effect of mersalyl administration on the PD was reversed
immediately when p-chloromercuribenzoate (PCMB) was sub-
stituted for the mersalyl. The reversal was more rapid with
PCMB than spontaneously (Fig. 1).
106 io— io— io—
Mersalyl concentration, M
Fig. 2. The maxima! inhibition of the PD by mersalyl in the
lumen of the thick ascending limb of Henle's loop was approxi-
mately 50% and was reached at a concentration of 10 M mer-
salyl in the lumen. The PD indicated is the stable value reached
5 to 10 mm after the drug was added. The pH of the perfusate
containing mersalyl was 7.4 (.) or 6.0 to 6.5 () (results of
32 measurements in 27 tubules).
Control Mersalyl PCMB a or
PCMB + mersalyl
Fig. 4. Inhibition of the PD across the thick ascending limb of
Henle's loop by mersalyl (3 X 10 M in the lumen) was reversed
by the addition of p-chloromercuribenzoate (PCMB, 10—s M,
3 tubules; 3 x io— M, 8 tubules) whether the PCMB replaced
mersalyl (A) or was added to it (s). The PD indicated with
mersalyl is the stable value reached 5 to 10 mm after addition
of the drug. The PD with PCMB or PCMB+ mersalyl is maxi-
mum value reached immediately after adding the PCMB.
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active Cl transport across the cortical thick ascending limb
of Henle's loop and thus decreases net NaC1 reabsorption.
Mersalyl ( 10 M) added to the lumen caused the PD
to decrease to a mean value of 48 2% of the control
(30 measurements in 27 tubules). The effect did not differ
appreciably over the concentration range from 10 to
3 X 10 M (Fig. 2). In contrast, furosemide or ethacrynic
acid inhibit to a greater extent. Addition of 10 M of the
latter drugs caused a greater decrease in the PD (and Cl
transport) than did mersalyl [9, 181. This difference is
consistent with the observation that furosemide and
ethacrynic acid produce a greater maximum diuresis in vivo
than do the mercurial diuretics [2].
Mercurials have a wide range of biological actions be-
cause of the toxic heavy metal which they contain. Therefore,
inhibition of a transport process in kidney tissue in vitro
is not necessarily related to the diuresis observed in vivo.
In order to investigate whether the action of mersalyl just
described is responsible for diuresis, the additional effect
of the nondiuretic mercurial p-chloromercuribenzoate was
tested. Both the mercurial diuretics and p-chloromercuri-
benzoate previously were found to inhibit electrolyte
transport in kidney slices [19, 20] and tubule suspensions
(Burg M. B., unpublished observations) and to inhibit the
renal Na and K-activated ATPase [21]. In contrast, the
diuretic action of mercurials in vivo is reversed by addition
of p-chloromercuribenzoate [22,23]. In the present studies,
when p-chloromercuribenzoate (1 to 3 x l0 M) replaced
mersalyl in the lumen, the PD returned immediately to the
control value (Fig. 3). The reversal was much more rapid
than when mersalyl was simply removed (Fig. 1). Addition
of p-chloromercuribenzoate also reversed the mersalyl
effect despite the continued presence of mersalyl in the
lumen (Fig. 4). Therefore, p-chloromercuribenzoate in the
lumen of the cortical thick ascending limb of Henle's loop
in vitro reverses the inhibitory effect of mersalyl, exactly
analogous to the result in vivo, providing evidence that the
in vitro effect is the cause of at least part of the diuresis
observed in vivo.
The action of mercurial diuretics is enhanced by prior
administration of acidifying salts such as NH4CI [24].
Consequently, it was postulated that the diuretic action
of mercurials requires an acid pH in the tubule lumen [1].
In the present experiments, mersalyl was as effective at
pH 7.4 in the perfusate as at pH of 6.0 to 6.5 (Fig. 2), which
is contrary to this theory (in the absence of the drug there
was no difference in the steady state PD with variation of
lumen pH between 6.0 and 8.0).
It has also been proposed [1, 25] that mercuric ions are
released from the organic mercurial diuretics and that the
mercuric ion is the actual effective form of the drug. In the
present experiments, addition of mercuric chloride to the
lumen inhibited the PD across the cortical thick ascending
limb of Henle's loop. The concentration of HgCI2
(3 x 10—6 M) was lower than that of mersalyl, but the
HgCl2 took longer to act (compare Fig. 5 to Figs. I and 3).
Fig. 5. The addition of mercuric chloride to the lumen caused
inhibition of the PD across the thick ascending limb of Henle's
loop at a concentration of3x 1O M. The inhibition, however,
did not reverse when p-chloromercuribenzoate (PCMB) was
substituted for the HgCl2.
The mean PD 18 to 30 minutes after HgCI2 was placed in
the lumen was 2.3 my (four tubules studied)
compared to 7.3 1.7 my, control PD in the same tubules.
In contrast to its reversal of the mersalyl effect, addition of
p-chloromercuribenzoate to the lumen (l0 to 3 x 10 M)
did not reverse the effect of HgCl2 in the lumen. The
maximum PD during 2 to 5 minutes following substitution
of p-chloromercuribenzoate was only 0.3 0.3 my [3].
Therefore, release of mercuric ion into the tubule fluid
cannot account for the action of the mercurial diuretics.
Either mercuric ion is released within the tissue or, more
likely, the intact molecule of the organic mercurial itself is
the effective form of the drug, rather than the mercuric ion.
Mercuric cysteine is a potent diuretic [26, 27]. In the
present experiments, however, even a very high concentra-
tion of mercuric cysteine (l0 M of Hg mixed with
2.2 x 10 M cysteine, pH 6.5 to 7.4) in the tubule lumen had
little effect on the PD. In 4 experiments the mean PD was
6.8 my 1.25 SEM in the control periods, 6.4 0.9 my
during 10 to 15 minutes of perfusion with the mercuric
cysteine, and 6.9 0.9 my in the postcontrol periods. The
discrepancy between the in vivo and in vitro results could be
explained if mercuric cysteine acted at a site other than the
lumen of the thick ascending limb, or was altered in the
body to a different chemical form.
Since the principal excretory product of mersalyl in the
urine is the cysteine complex of mersalyl [25], it is possible
that this complex, rather than mersalyl itself, is present in
the lumen of the thick ascending limb of Henle's loop













into the tubule lumen in vitro (mersalyl 10' to i0 Mplus
10% molar excess of cysteine), it caused the PD to decrease
to a mean value of 66 6% of the control value (E/C,
13 measurements in 9 tubules). Therefore, both mersalyl
and its cysteine complex can inhibit the PD in the cortical
thick ascending limb of Henle's loop in vitro, and either
might be the effective form in vivo. Mersalyl itself, however,
is somewhat more potent (as just shown). There was no
effect of varying pH in the lumen on the action of the
mersalyl cysteine complex (E/C =0.66 0.11 [5] at pH 6.5;
0.65 [8] at pH 7.4 to 7.6).
Mersalyl in the bath also inhibited the PD, but the effect
was different from that in the lumen. Even with no protein
present in the bath, the minimum effective concentration of
mersalyl was higher (10 M, Fig. 6) than in the lumen
(3 x 10—6 to 10', Fig. 2) and the rate of decrease of the PD
was slower (compare Fig. 6 to Figs. 1 and 3). Further, the
effect of mersalyl in the bath did not reverse spontaneously
nor with the addition of p-chloromercuribenzoate to the
lumen or bath (Fig. 6).
In order to test whether the effect of the addition of
mersalyl to the lumen of the cortical thick ascending limb
of Henle's loop is accompanied by a major change in Na or





Fig. 6. Effect of mersalyl in the bath on the thick ascending limb
of Henle's loop. P-chloromercunbenzoate (PCMB) added to the
lumen or bath did not reverse the effect of mersalyl in the bath,
contrary to the result when mersalyl was perfused (Fig. 3). A
third experiment in which the results were otherwise identical
is not shown since the timing was different. The bath and
perfusate were artificial saline buffers free of added protein
(see Methods).
Table 2. Effect of mersalyl and NaCI concentration in the lumen












Tubule 1 7.5 22.3 3.8 22.8
Tubule 2 8.3 26.5 4.5 23.4
Tubule 3 8.0 30.0 4.3 22.8
Tubule 4 6.9 23.0 2.4 15.0
Mean 7.7 25.5 3.8 21.0
Difference 17.8 17.3
a Each value of the PD is the mean of two readings taken one
minute apart. The perfusate with 50 mEq/liter of NaCl was
otherwise identical to that containing 150 mEq/liter'.
resistance were measured. When the thick ascending limb
is perfused with a solution which contains a lower NaCI
concentration than in the bath, the electrical PD increases.
This is a consequence of a diffusion potential across the
epithelium, resulting from the imposed chemical concentra-
tion gradient (Na conductance exceeds Cl conductance)
[7]. All other things being equal, the magnitude of the
diffusion potential depends on the ratio of Na to Cl
conductance. In the experiments in Table 2, tubules were
perfused with solutions containing both a normal (150 mM)
anda low (50 mM) NaCI concentration. The mean difference
in PD with the two solutions was approximately the same
whether mersalyl was present (17.3 my difference) or absent
(17.8 my difference) indicating little change in the ratio
of Na to Cl permeabilities with the drug. The addition of
mersalyl (3 x 10 M in the lumen) also caused no definite
change in the transepithelial electrical resistance. In
5 experiments the mean resistance was 3620 ohm cm in
control periods (C), 3860 with mersalyl in the lumen (E),
and 3570 afterp-chloromercuribenzoate (10 M) was added
and the PD had returned to the control value (C'). The
difference E— C± C was + 267±106, p >0.05. Thus, it
is unlikely that the drug causes any major change in Na or
Cl permeability. The addition of furosemide to the lumen
was previously noted to cause a small decrease in Na and
Cl permeability [9]. A similar, but lesser, decrease in per-
meability from mersalyl is not excluded by the present
results.
Discussion
On the basis of the present results, mersalyl inhibits
active Cl transport in the cortical thick ascending limb of
Henle's loop. Schwartz [28] and Axelrod and Pitts [29]
previously called attention to the disproportionately large
amount of Cl which appears in the urine following ad-
ministration of mercurial diuretics. They proposed that the
mercurials primarily inhibited Cl transport. At that time,






nephron was not recognized, and, since the result could
be rationalized in another manner [4], their idea was not
generally accepted. The inhibition of Cl transport, which
they proposed and which has been directly demonstrated
in the present studies to occur in the cortical thick ascending
limb of Henle's loop, is a renal action of mercurials which
accounts, at least in part, for their diuretic effect. Hopefully,
future direct examination of the effect of mercurials on the
other parts of the kidney tubule will determine whether
inhibition of the other segments is also important in the
diuresis.
P-chloromercuribenzoate antagonizes the diuretic action
of the mercurials both in vivo [22, 23] and in vitro (present
experiments). Miller and Farah [22, 231 accepted, following
Weiner et al. [1, 25], that mercuric ions released from
organic mercurials are the effective diuretic form, and they
proposed that p-chloromercuribenzoate displaces the
mercuric ions from a renal receptor, but is itself non-
diuretic, owing to a different form of binding to the
receptor. In the present studies, the effects of mercuric
chloride in the lumen differed significantly from those with
mersalyl. One possible explanation for this difference is
that the organic mercurial molecule must be intact to exert
its characteristic effect [30]. In that case, it is necessary to
assume that p-chloromercuribenzoate displaces the organic
mercurial molecule itself from the receptor site, rather than
the mercuric ion.
These are a number of possible explanations as to why
p-chloromercuribenzoate reversed the effect of mersalyl in
the lumen, but not of HgCl2 in the lumen nor of mersalyl
in the bath. The one which we favor is that the mercurials
might have more than one effect on the thick ascending limb
of Henle's loop. The first effect is that associated with the
in vivo diuresis. It is caused by diuretic mercurials in the
tubule lumen and reversed byp-chloromercuribenzoate. The
second is a nonspecific effect caused by HgC12 and by high
concentrations of mersalyl in the bath. The two effects might
correspond to two different sites of action. The first site
could be on the lumen surface and could explain why the
diuretic effect is so rapidly reversed by p-chloromercuri-
benzoate. The second site could be within the tubule cells.
The relatively slow but irreversible inhibitory action of the
mercurials could result from gradual entry of these com-
pounds into the cells and subsequent toxic inhibition of the
cellular metabolic processes. It is possible that in vivo the
cells could be protected from this toxic effect by binding of
mercurials by proteins in the plasma or complexing of
mercuric ions with amino acids such as cysteine in the
tubule fluid.
The probability that the mercurial diuretics act from
inside the lumen has been recognized for some time [1, 3].
The question of the pathway by which they reach the tubule
fluid, however, is unresolved. Binding of the mercurials to
plasma proteins presumably restricts their glomerular
filtration rate, but glomerular filtration is not entirely ruled
out as a pathway [1, 3]. Secretion of mercurials by proximal
tubule cells is a more likely pathway, but there are impor-
tant differences between species and between the tubular
handling of the various mercurial diuretics, and the exact
mechanism remains uncertain [1, 3].
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